Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Current Assets: 2020-2023

Historic Current Assets for Immuneering (IMRX) over the last 4 years, with Dec 2023 value amounting to $89.1 million.

  • Immuneering's Current Assets fell 45.06% to $55.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was $55.3 million, marking a year-over-year decrease of 45.06%. This contributed to the annual value of $89.1 million for FY2023, which is 18.08% down from last year.
  • Latest data reveals that Immuneering reported Current Assets of $89.1 million as of FY2023, which was down 18.08% from $108.7 million recorded in FY2022.
  • Over the past 5 years, Immuneering's Current Assets peaked at $152.3 million during FY2021, and registered a low of $37.7 million during FY2020.
  • For the 3-year period, Immuneering's Current Assets averaged around $116.7 million, with its median value being $108.7 million (2022).
  • In the last 5 years, Immuneering's Current Assets soared by 303.73% in 2021 and then fell by 28.61% in 2022.
  • Immuneering's Current Assets (Yearly) stood at $37.7 million in 2020, then skyrocketed by 303.73% to $152.3 million in 2021, then dropped by 28.61% to $108.7 million in 2022, then fell by 18.08% to $89.1 million in 2023.